FR5132M - - Google Patents
Info
- Publication number
- FR5132M FR5132M FR46556A FR46556A FR5132M FR 5132 M FR5132 M FR 5132M FR 46556 A FR46556 A FR 46556A FR 46556 A FR46556 A FR 46556A FR 5132 M FR5132 M FR 5132M
- Authority
- FR
- France
- Prior art keywords
- tablets
- lysozyme
- amylase
- jan
- suitably
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108090000790 Enzymes Proteins 0.000 abstract 3
- 102000004190 Enzymes Human genes 0.000 abstract 3
- 102000016943 Muramidase Human genes 0.000 abstract 3
- 108010014251 Muramidase Proteins 0.000 abstract 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 3
- 229940088598 enzyme Drugs 0.000 abstract 3
- 235000010335 lysozyme Nutrition 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000004382 Amylase Substances 0.000 abstract 2
- 102000013142 Amylases Human genes 0.000 abstract 2
- 108010065511 Amylases Proteins 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 235000019418 amylase Nutrition 0.000 abstract 2
- 229960000274 lysozyme Drugs 0.000 abstract 2
- 239000004325 lysozyme Substances 0.000 abstract 2
- 239000003826 tablet Substances 0.000 abstract 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 abstract 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract 1
- 108090000317 Chymotrypsin Proteins 0.000 abstract 1
- 102000002322 Egg Proteins Human genes 0.000 abstract 1
- 108010000912 Egg Proteins Proteins 0.000 abstract 1
- 108010003272 Hyaluronate lyase Proteins 0.000 abstract 1
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract 1
- 239000001166 ammonium sulphate Substances 0.000 abstract 1
- 235000011130 ammonium sulphate Nutrition 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000000440 bentonite Substances 0.000 abstract 1
- 229910000278 bentonite Inorganic materials 0.000 abstract 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 abstract 1
- 229960002376 chymotrypsin Drugs 0.000 abstract 1
- 238000000502 dialysis Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 235000014103 egg white Nutrition 0.000 abstract 1
- 210000000969 egg white Anatomy 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 210000004251 human milk Anatomy 0.000 abstract 1
- 235000020256 human milk Nutrition 0.000 abstract 1
- 229960002773 hyaluronidase Drugs 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 108010032809 mucopolysaccharidase Proteins 0.000 abstract 1
- 210000003097 mucus Anatomy 0.000 abstract 1
- 229940051921 muramidase Drugs 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000006190 sub-lingual tablet Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 210000001138 tear Anatomy 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- -1 unit dosage packets Substances 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
1,171,183. Compositions containing enzymes. CENTRE D'ETUDES POUR L'lNDUSTRIE PHARMACEUTIQUE. 12 Jan., 1967 [20 Jan., 1966], No. 1785/67. Heading A5B. Pharmaceutical compositions, having antiinflammatory and anti-oedematous activity, comprise a mixture of amylase and lysozyme (muramidase) together with a pharmaceutically acceptable vehicle. The amylase may be of bacterial, animal or vegetable origin, suitably being prepared from mushrooms. Lysozyme, which may be found in nasal mucus, saliva, tears, human milk or egg white, is suitably prepared from the latter, in aqueous solution, by absorption on bentonite, with elution of the enzyme with aqueous pyridine of pH 5.0, followed by precipitation with ammonium sulphate, dialysis and desiccation of the product. The compositions preferably also contain chymotrypsin, and mucopolysaccharidases (chondrosulphatase and hyaluronidase), or other depolymerising or hydrolytic enzymes. They may be in the forms for oral or topical administration, such as tablets, coated tablets, sublingual tablets, syrup, unit dosage packets, ointments, or spray solutions for use in an atomiser.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR46556A FR5132M (en) | 1966-01-20 | 1966-01-20 | |
| GB178567A GB1171183A (en) | 1966-01-20 | 1967-01-12 | Pharmaceutical Compositions containing Enzymes |
| BE692682D BE692682A (en) | 1966-01-20 | 1967-01-16 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR46556A FR5132M (en) | 1966-01-20 | 1966-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR5132M true FR5132M (en) | 1967-06-05 |
Family
ID=8599230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR46556A Expired FR5132M (en) | 1966-01-20 | 1966-01-20 |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE692682A (en) |
| FR (1) | FR5132M (en) |
| GB (1) | GB1171183A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9207280D0 (en) * | 1992-04-02 | 1992-05-13 | Unilever Plc | Skin care method and composition |
| GB9207288D0 (en) * | 1992-04-02 | 1992-05-13 | Unilever Plc | Cosmetic composition |
| CA3014764A1 (en) | 2016-02-25 | 2017-08-31 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| US12447166B2 (en) | 2016-02-25 | 2025-10-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| US12594285B2 (en) | 2016-02-25 | 2026-04-07 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
-
1966
- 1966-01-20 FR FR46556A patent/FR5132M/fr not_active Expired
-
1967
- 1967-01-12 GB GB178567A patent/GB1171183A/en not_active Expired
- 1967-01-16 BE BE692682D patent/BE692682A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE692682A (en) | 1967-07-03 |
| GB1171183A (en) | 1969-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE812972L (en) | Actaplanin derivatives | |
| MY104013A (en) | Drug adsorbates. | |
| UA29450C2 (en) | Derivatives of hydroxamic acid, a PROCESS for PREPARATION thereof, a method for influence on diseases and pharmaceutical composition containing them | |
| WO2000050069A1 (en) | A means for the prophylactic and therapeutic treatment of streptococcal infections | |
| HUP9701437A2 (en) | Use of complex lipides as stabilizing additives in pharmaceutical compositions containing digestive enzymes, pharmaceutical compns. and kits | |
| ATE261494T1 (en) | CONSTRUCTS FOR ADMINISTRATION OF THERAPEUTIC ACTIVE INGREDIENTS TO NEURON CELLS | |
| GB1171183A (en) | Pharmaceutical Compositions containing Enzymes | |
| US3590121A (en) | Effervescent dental compositions | |
| IE36619L (en) | Enzymes for reducing dental plaque | |
| ATE65914T1 (en) | PHARMACEUTICALS CONTAINING PENTAMIDINE. | |
| ES2023727A6 (en) | Pharmaceutical solution containing salbutamol and cromoglycic acid. | |
| ATE218368T1 (en) | MEDICATION CONTAINING PROTEIN C ACTIVATION PEPTIDE | |
| GB1196971A (en) | Production of Fortified Sugar | |
| GB1224281A (en) | Process for purifying starch and purified starch and products containing same | |
| GB1035060A (en) | Improved processes for the extraction of proteins and other useful constituents contained in vegetable tissues | |
| IE810808L (en) | Isophthalic acid picolylamide monohydrate | |
| IE34806B1 (en) | Pharmaceutical compositions | |
| GB1482651A (en) | Pharmaceutical products | |
| IE34609L (en) | Therapeutic substituted thiazolidinedione | |
| GB1235540A (en) | Oral preparations containing proteolytic enzymes suitable for pediatric use | |
| GB1327560A (en) | Effervescent pharmaceutical preparations | |
| IE36320B1 (en) | Enzyme treatment of legumes and derived products | |
| CA2046598A1 (en) | T-pa solubilisation | |
| IT1214915B (en) | 4-METHOXYISOPHTALIC ACID DERIVATIVES WITH PHARMACOLOGICAL ACTIVITY IN THROMBOEMBOLIC DISORDERS AND PROCEDURE FOR ITS PREPARATION | |
| IE34386L (en) | Acetylsalicylic acid-containing composition |